Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Castration-naïve prostate cancer"'
Autor:
Manato Kanesaka, Shinichi Sakamoto, Yasutaka Yamada, Junryo Rii, Maihulan Maimaiti, Tomokazu Sazuka, Yusuke Imamura, Akira Komiya, Koichiro Akakura, Yuzuru Ikehara, Hiroomi Nakatsu, Tomohiko Ichikawa
Publikováno v:
Prostate International, Vol 9, Iss 4, Pp 208-214 (2021)
Background: To identify the real high-risk group among Japanese de novo metastatic prostate cancer patients who fit CHAARTED or LATITUDE criteria. Methods: We retrospectively studied patients who fitted CHAARTED (292 patients) and LATITUDE (294 patie
Externí odkaz:
https://doaj.org/article/1905ecc037294ff2af5fe8287ef16bfe
Autor:
Sang Eun Yoon, Youjin Kim, Jangho Cho, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byoung Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Su Jin Lee, Se Hoon Park
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Results from randomized phase III trials have shown that thrice-weekly docetaxel added to androgen-deprivation therapy (ADT) has a significant impact on the survival of patients with metastatic castration-naïve prostate cancer (m
Externí odkaz:
https://doaj.org/article/90b5db2fca394bd5839199b337a90816
Autor:
Koichiro Akakura, Yuzuru Ikehara, Akira Komiya, Hiroomi Nakatsu, Tomokazu Sazuka, Tomohiko Ichikawa, Yasutaka Yamada, Junryo Rii, Manato Kanesaka, Yusuke Imamura, Shinichi Sakamoto, Maihulan Maimaiti
Publikováno v:
Prostate International, Vol 9, Iss 4, Pp 208-214 (2021)
Prostate International
Prostate International
Background: To identify the real high-risk group among Japanese de novo metastatic prostate cancer patients who fit CHAARTED or LATITUDE criteria. Methods: We retrospectively studied patients who fitted CHAARTED (292 patients) and LATITUDE (294 patie
Autor:
Charles G. Drake, Matthew R. Smith, Almudena Zapatero, Charles J. Ryan, Philip W. Kantoff, Piet Ost, Inge M. van Oort, Ian D. Davis, Nicolas James, Matthew R. Sydes, Vedang Murthy, Martin E. Gleave, Maha Hussain, Michael S Hofman, Susan Halabi, Ignacio Duran, Oliver Sartor, Raya Leibowitz, Christopher P. Evans, Anders Bjartell, Ros Eeles, Mack Roach, Hiroyoshi Suzuki, Colin C. Pritchard, Levent Türkeri, Daniel Heinrich, Fred Saad, William Oh, Karim Fizazi, Himisha Beltran, Declan G. Murphy, Joe M. O'Sullivan, Thomas Steuber, Raja B. Khauli, Axel Heidenreich, Silke Gillessen, Eric J. Small, Robert E. Reiter, Juan Pablo Sade, Chris Logothetis, Tomasz M. Beer, Alberto Briganti, Mary-Ellen Taplin, Johann S. de Bono, Howard I. Scher, Eleni Efstathiou, Stefano Fanti, Darren M.C. Poon, Felix Y. Feng, Aurelius Omlin, Hind Mrabti, Chris Parker, Anwar R. Padhani, Kim N. Chi, Mark A. Rubin, Neal D. Shore, Nicolas Mottet, Alicia K. Morgans, Christopher Sweeney, Mark Frydenberg, Robert G. Bristow, Fernando C. Maluf, Robin Millman, Cora N. Sternberg, Ravindran Kanesvaran, Michael J. Morris, Noel W. Clarke, Gerhardt Attard, Alberto Bossi, Bertrand Tombal, Celestia S. Higano, Howard R. Soule
Publikováno v:
EUROPEAN UROLOGY
European Urology, Vol. 77, no. 4, p. 508-547 (2020)
European Urology, 77, 508-547
European urology, vol 77, iss 4
European Urology, 77, 4, pp. 508-547
European Urology, Vol. 77, no. 4, p. 508-547 (2020)
European Urology, 77, 508-547
European urology, vol 77, iss 4
European Urology, 77, 4, pp. 508-547
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced
Autor:
Rachael Kit Tsan Khong, Rohan Malek, Teng Aik Ong, Chong Beng Chua, Guan Chou Teh, Adlinda Alip, Fuad Ismail, Hwoei Fen Soo Hoo, Marniza Saad, Pei Jye Voon, Chit Sin Loh, Flora Li Tze Chong, Muthukkumaran Thiagarajan, Jasmine Lim, Noor Azam Nasuha, Murali Sundram, Khairul Asri Mohd Ghani, Ibtisam Md Noor, Chun Sen Lim, Azad Hassan Abdul Razack, Hui Meng Tan, Matin Mellor Abdullah, Noor Ashani Md Yusoff
Publikováno v:
Bju International
Objective To examine the results of the Malaysian Advanced Prostate Cancer Consensus Conference (MyAPCCC) 2018, held for assessing the generalizability of consensus reached at the Advanced Prostate Cancer Consensus Conference (APCCC 2017) to Malaysia
Autor:
Hwang Gyun Jeon, Jang Ho Cho, Seong Il Seo, Hyun Moo Lee, Han Yong Choi, Sang Eun Yoon, Hyun Hwan Sung, Minyong Kang, Seong Soo Jeon, Youjin Kim, Se Hoon Park, Su Jin Lee, Byoung Chang Jeong
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-6 (2019)
BMC Urology
BMC Urology
Background Results from randomized phase III trials have shown that thrice-weekly docetaxel added to androgen-deprivation therapy (ADT) has a significant impact on the survival of patients with metastatic castration-naïve prostate cancer (mCNPC) and
Autor:
Gillessen, Silke, Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Bossi, Alberto, Briganti, Alberto, Bristow, Rob G., Chi, Kim N., Clarke, Noel, Davis, Ian D., de Bono, Johann, Drake, Charles G., Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Evans, Christopher P., Fanti, Stefano, Feng, Felix Y., Fizazi, Karim, Frydenberg, Mark, Gleave, Martin, Halabi, Susan, Heidenreich, Axel, Heinrich, Daniel, Higano, Celestia (Tia) S., Hofman, Michael S., Hussain, Maha, James, Nicolas, Kanesvaran, Ravindran, Kantoff, Philip, Khauli, Raja B., Leibowitz, Raya, Logothetis, Chris, Maluf, Fernando, Millman, Robin, Morgans, Alicia K., Morris, Michael J., Mottet, Nicolas, Mrabti, Hind, Murphy, Declan G., Murthy, Vedang, Oh, William K., Ost, Piet, O'Sullivan, Joe M., Padhani, Anwar R., Parker, Chris, Poon, Darren M.C., Pritchard, Colin C., Reiter, Robert E., Roach, Mack, Rubin, Mark, Ryan, Charles J., Saad, Fred, Sade, Juan Pablo, Sartor, Oliver, Scher, Howard I., Shore, Neal, Small, Eric, Smith, Matthew, Soule, Howard, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sweeney, Christopher, Sydes, Matthew R., Taplin, Mary Ellen, Tombal, Bertrand, Türkeri, Levent, van Oort, Inge, Zapatero, Almudena, Omlin, Aurelius
Publikováno v:
Gillessen, S, Attard, G, Beer, T M, Beltran, H, Bjartell, A, Bossi, A, Briganti, A, Bristow, R G, Chi, K N, Clarke, N, Davis, I D, de Bono, J, Drake, C G, Duran, I, Eeles, R, Efstathiou, E, Evans, C P, Fanti, S, Feng, F Y, Fizazi, K, Frydenberg, M, Gleave, M, Halabi, S, Heidenreich, A, Heinrich, D, Higano, C S, Hofman, M S, Hussain, M, James, N, Kanesvaran, R, Kantoff, P, Khauli, R B, Leibowitz, R, Logothetis, C, Maluf, F, Millman, R, Morgans, A K, Morris, M J, Mottet, N, Mrabti, H, Murphy, D G, Murthy, V, Oh, W K, Ost, P, O'Sullivan, J M, Padhani, A R, Parker, C, Poon, D M C, Pritchard, C C, Reiter, R E, Roach, M, Rubin, M, Ryan, C J, Saad, F, Sade, J P, Sartor, O, Scher, H I, Shore, N, Small, E, Smith, M, Soule, H, Sternberg, C N, Steuber, T, Suzuki, H, Sweeney, C, Sydes, M R, Taplin, M E, Tombal, B, Türkeri, L, van Oort, I, Zapatero, A & Omlin, A 2020, ' Management of Patients with Advanced Prostate Cancer : Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented] ', European Urology, vol. 77, no. 4, pp. 508-547 . https://doi.org/10.1016/j.eururo.2020.01.012
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::44074e6928ac7620fb1ae5a650bf32af
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.